Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Healthy Volunteer × poly ICLC × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 5 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Ovarian Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Glioblastoma 2 Uterine Cervical Dysplasia 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Neoplasms, Plasma Cell 1 Healthy Volunteer 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Chondrosarcoma 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

poly ICLC 1 keyhole-limpet hemocyanin 1 Photosensitizing Agents 1 Peptides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02947854 2019-08-28

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

PCI Biotech AS

Phase 1 Completed

Healthy Volunteer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡